Abstract
Brain atrophy assessment in MRI, particularly of the hippocampus, is commonly used to support diagnosis and monitoring of dementia. Consequently, there is a demand for accurate automated hippocampus quantification. Most existing segmentation methods have been developed and validated on research datasets and, therefore, may not be appropriate for clinical MR images and populations, leading to potential gaps between dementia research and clinical practice. In this study, we investigated the performance of segmentation models trained on research data that were style-transferred to resemble clinical scans. Our results highlighted the importance of intensity normalisation methods in MRI segmentation, and their relation to domain shift and style-transfer. We found that whilst normalising intensity based on min and max values, commonly used in generative MR harmonisation methods, may create a need for style transfer, Z-score normalisation effectively maintains style consistency, and optimises performance. Moreover, we show for our datasets spatial augmentations are more beneficial than style harmonisation. Thus, emphasising robust normalisation techniques and spatial augmentation significantly improves MRI hippocampus segmentation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419736/
https://bmjopen.bmj.com/content/13/8/e067808
Funding Statement
The authors are grateful for support from: the University of Oxford Department of Computer Science Scholarship (HK), the Bill and Melinda Gates Foundation (NKD, AILN) and the Presidential Postdoctoral Fellowship (Nanyang Technological University) (PHY). We are grateful to the operations team of the OBHC. The OHBC data collection and analysis is supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316) - a partnership between the University of Oxford and Oxford Health NHS Foundation Trust, the NIHR Oxford Cognitive Health Clinical Research Facility, and the Wellcome Centre for Integrative Neuroimaging (203139/Z/16/Z,203139/A/16/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the Health Research Authority (South Central, Oxford C (SC/19/0404)) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
HarP dataset is available online. Access to the OHBC dataset can be requested via DPUK.
